Company Adds Tom Moore as Chief Commercial Officer and Sandeep Yadav as Chief Financial OfficerContinue reading
Category Archives: AZBio News
Tucson Eye Care Company iCRx Joins UA Tech Park
TUCSON, Ariz. – iCRx, a leader in eye care innovation through optic technology, announced today its move to the University of Arizona (UA) Tech Park. Their new facility includes office and laboratory space that enable cutting-edge optical research. This announcement is a milestone for the Tucson-based company as it prepares to unveil its groundbreaking One-Minute Eye Exam technology.Continue reading
In Memoriam – Lee Gerdes, Inventor and Founder of Cereset
Lee Gerdes, serial entrepreneur and the inventor of Cereset, passed away peacefully Sunday evening, June 16th 2024, with family by his side. Lee succumbed to complications related to his long-time battle with cancer. Lee dedicated his life to helping others, and he will be greatly missed, but his legacy lives on in Cereset.
Innovative Nevada Based Company Focused on Developing Patented Therapeutic and Pharmaceutical Formulations with Enhanced Efficacy Wins Incubation Support through the University of Arizona in Collaboration with Oro Valley
TUCSON, AZ. — The University of Arizona Center for Innovation (UACI) is pleased to announce the winning company for the UACI Sponsored Launch Fueled by the Oro Valley Chamber of Commerce and Town of Oro Valley competition. CellMedics Inc., will receive support in the UACI incubation program including resources, facilities, services and expert guidance to grow its business.Continue reading
C-Path Partners with FARA to Fortify RDCA-DAP and Further Accelerate Drug Development with New Friedreich’s Ataxia Data
The team also announced the closure of the FA-ICD portal. Continue reading
Calviri Announces Completion of Groundbreaking Preventative Canine Cancer Vaccine Trial
PHOENIX, June 3, 2024 /PRNewswire/ — Calviri, Inc. announced the successful conclusion of the Vaccine Against Canine Cancer Study (VACCS) on May 4, 2024; a five-year clinical trial investigating a novel preventative cancer vaccine in dogs. This multi-center, double-blind, placebo-controlled study, the largest of its kind in veterinary oncology, represents a significant milestone in the fight against canine cancer.Continue reading
AZBioPEERS: IP Essentials
This insightful pre-recorded webinar on intellectual property is tailored for life science startups and presented by Jason Jardine, AZBio board member and partner at Knobbe Martens. Continue reading
Flinn Foundation-sponsored study identifies three bioscience growth areas to advance innovation and economic growth in greater Phoenix
Precision oncology/medicine, digital health, translational neurosciences to advance Phoenix Bioscience Core, new hubsContinue reading
C-Path’s Parkinson’s Consortium Supports Groundbreaking Research Utilizing Smartwatches to Monitor Disease Progression
TUCSON, Ariz., June 12, 2024 — Critical Path Institute (C-Path) today announced a new publication on how the use of wearable technology can optimize measuring symptoms important to people with Parkinson’s disease. The newly published manuscript in npj Parkinson’s Disease highlights a multistakeholder initiative consisting of collaborators from around the world coming together to share knowledge, data and resources to ask how new technologies can help to monitor people living with Parkinson’s in new ways.
C-Path’s AI Collaborations Accelerate Drug Development, Improve Lives
TUCSON, Ariz., June 12, 2024 — Critical Path Institute (C-Path) today announced the publication of a new peer-reviewed paper in the journal Clinical and Translational Science. As the preeminent leader in public-private partnerships to accelerate drug development, the paper highlights how C-Path’s AI collaborations are revolutionizing drug development, with specific advancements in the management and treatment of Type 1 Diabetes (T1D) and Parkinson’s Disease (PD). This study affirms the Institute’s commitment to using artificial intelligence (AI) and digital health technologies (DHTs) to expedite the delivery of life-saving treatments.